Journal article
A phase II study of single agent abraxane as second-line therapy in patients with advanced urothelial carcinoma
Abstract
e16058
Authors
Sridhar SS; Canil CM; Eisen A; Tannock IF; Knox JJ; Reaume N; Mukherjee SD; Winquist E; Chung A; Ko YJ
Journal
Journal of Clinical Oncology, Vol. 27, No. 15_suppl, pp. e16058–e16058
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2009
DOI
10.1200/jco.2009.27.15_suppl.e16058
ISSN
0732-183X